Park, Min-Chan
Matsuno, Hiroaki
Kim, Jinseok
Park, Sung-Hwan
Lee, Sang-Heon
Park, Yong-Beom
Lee, Yun Jong
Lee, Sang-Il
Park, Won
Sheen, Dong Hyuk
Choe, Jung-Yoon
Choi, Chan-Bum
Hong, Seung-Jae
Suh, Chang-Hee
Lee, Shin-Seok
Cha, Hoon-Suk
Yoo, Bin
Hur, Jin-Wuk
Kim, Geun-Tae
Yoo, Wan-Hee
Baek, Han Joo
Shin, Kichul
Shim, Seung Cheol
Yang, Hyung-In
Kim, Hyun Ah
Park, Kyung-Su
Choi, In Ah
Lee, Jisoo
Tomomitsu, Masato
Shin, Seonghye
Lee, Jiyoon
Song, Yeong Wook http://orcid.org/0000-0002-5384-3437
Funding for this research was provided by:
LG Chem, Ltd. (formerly, LG Life Sciences, Ltd), Mochida Pharmaceutical Co., Ltd. and Korea Health Industry Development Institute
Article History
Received: 10 January 2019
Accepted: 7 May 2019
First Online: 21 May 2019
Ethics approval and consent to participate
: The study was approved by the institutional review board of all participating centres. All patients provided written informed consent prior to inclusion in the study.
: Not applicable.
: HM has received consulting fees for this study from Mochida Pharmaceutical Co., Ltd.; consulting fees from AYUMI Pharmaceutical Corporation and Nichi-Iko Pharmaceutical Co., Ltd.; and lecture fees from Daiichi Sankyo Co., Ltd., Chugai Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd., outside of this study. MT is an employee of Mochida Pharmaceutical Co., Ltd. SS and JY are employees of LG Chem, Ltd. All authors other than HM, MT, SS and JY received grants for this extension study from LG Chem, Ltd.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.